Veracyte | VCYT - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Agenus USD 35.32M 2.51M 2025-12
Agilent USD 282.7M 358K 2025-12
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 135.7M 2.44M 2025-09
Bruker USD 151.94M 225K 2025-12
Exact Sciences USD 189.45M 232K 2025-09
Heron Therapeutics USD 188.31M 4.99M 2025-12
Illumina USD 152.8M 900K 2025-12
Intrexon USD 0 0 2024-06
Karyopharm Therapeutics USD 13K 0 2024-09
Laboratory Of America USD 82.2M 700K 2025-12
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Myriad Genetics USD 93.5M 400K 2025-12
Rigel Pharmaceuticals USD 17K 158K 2024-06
Roche Holding CHF 795.62M 699.54K 2025-12
Siemens EUR 780.74M 6.33M 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
Veracyte USD 79.05M 377K 2025-12
Waters USD 98.08M 38.55M 2025-12